CONMED CORP's ticker is and the CUSIP is 207410AF8. A total of 46 filers reported holding CONMED CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $938 | -26.2% | 810,000 | 0.0% | 0.01% | -18.2% |
Q2 2023 | $1,271 | +27.1% | 810,000 | 0.0% | 0.01% | +22.2% |
Q1 2023 | $1,000 | +5.8% | 810,000 | 0.0% | 0.01% | +12.5% |
Q4 2022 | $945 | -100.0% | 810,000 | -81.2% | 0.01% | -85.7% |
Q3 2022 | $4,738,000 | -10.0% | 4,310,000 | 0.0% | 0.06% | -1.8% |
Q2 2022 | $5,263,000 | -28.9% | 4,310,000 | 0.0% | 0.06% | -16.2% |
Q1 2022 | $7,405,000 | +57.1% | 4,310,000 | +53.4% | 0.07% | +61.9% |
Q4 2021 | $4,714,000 | +7.8% | 2,810,000 | 0.0% | 0.04% | -12.5% |
Q3 2021 | $4,373,000 | -4.4% | 2,810,000 | 0.0% | 0.05% | +4.3% |
Q2 2021 | $4,576,000 | +3.6% | 2,810,000 | 0.0% | 0.05% | +4.5% |
Q1 2021 | $4,416,000 | -69.4% | 2,810,000 | -72.5% | 0.04% | -73.5% |
Q4 2020 | $14,415,000 | +46.7% | 10,200,000 | +17.2% | 0.17% | +33.9% |
Q3 2020 | $9,824,000 | +6.2% | 8,700,000 | 0.0% | 0.12% | +1.6% |
Q2 2020 | $9,248,000 | +17.2% | 8,700,000 | +3.6% | 0.12% | +2.5% |
Q1 2020 | $7,894,000 | – | 8,400,000 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Mohican Financial Management, LLC | 2,840,000 | $3,958,000 | 4.02% |
ZAZOVE ASSOCIATES LLC | 13,564,000 | $18,956,000 | 2.33% |
SHENKMAN CAPITAL MANAGEMENT INC | 10,584,000 | $15,014,000 | 1.57% |
SSI INVESTMENT MANAGEMENT LLC | 8,349,000 | $11,673,000 | 0.83% |
OSTERWEIS CAPITAL MANAGEMENT INC | 8,930,000 | $12,528,000 | 0.75% |
MACKAY SHIELDS LLC | 32,384,000 | $45,397,000 | 0.31% |
ADVENT CAPITAL MANAGEMENT /DE/ | 8,379,000 | $11,734,000 | 0.25% |
PALISADE CAPITAL MANAGEMENT, LP | 5,271,000 | $7,387,000 | 0.19% |
Calamos Advisors LLC | 23,007,000 | $32,262,000 | 0.19% |
WESTWOOD HOLDINGS GROUP INC | 10,200,000 | $14,415,000 | 0.17% |